Accuracy of a commercially available assay for HCV genotyping and subtyping in the clinical practice

Journal of Clinical Virology

Volumn 58, Issue 3, 2013, Pages 593-597

  González, Victoria ^a,b,c   Gomes Fernandes, Meissiner ^a   Bascuñana, Elisabet ^a   Casanovas, Sònia ^a   Saludes, Verónica ^a,b,e   Jordana Lluch, Elena ^a   Matas, Lurdes ^a,b   Ausina, Vicenç ^a,d   Martró, Elisa ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Centre for Epidemiological Studies on HIV STI in Catalonia (CEEISCAT) ICO   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Genotyping; Hepatitis C virus; Phylogenetic analysis; Real time PCR; Subtyping

Indexed keywords

ACCURACY; ADULT; CLINICAL PRACTICE; ERRATUM; FEMALE; GENE SEQUENCE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84886302930     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.09.010     Document Type: Erratum

References (21)

1. World Health Organization (WHO) Hepatitis C: WHO Fact Sheet N(164) 2013, http://www.who.int/mediacentre/factsheets/fs164/en/.
2. Simmonds P., Bukh J., Combet C., Deleage G., Enomoto N., Feinstone S., et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005, 42:962-973.
3. Ghany M.G., Strader D.B., Thomas D.L., Seeff L.B. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49:1335-1374.
4. Kieffer T.L., Sarrazin C., Miller J.S., Welker M.W., Forestier N., Reesink H.W., et al. Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients. Hepatology 2007, 46:631-639.
5. McCown M.F., Rajyaguru S., Kular S., Cammack N., Najera I. GT-1a or GT-1b subtype-specific resistance profiles for hepatitis C virus inhibitors telaprevir and HCV-796. Antimicrob Agents Chemother 2009, 53:2129-2132.
6. Cento V., de Lucas F., Landonio S., Cucchiarelli S., di Maio V.C., Micheli V., et al. Performing a genotypic resistance test before staring a PI-based regimen: characterization of a failure of boceprevir treatment in a patient infected with HCV-genotype 1g. Poster presented at: Therapy of Hepatitis C: Clinical Application and Drug Development. EASL/AASLD Special Conference 2012.
7. Martró E., González V., Buckton A.J., Saludes V., Fernández G., Matas L., et al. Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5' noncoding and nonstructural 5b genomic regions. J Clin Microbiol 2008, 46:192-197.
8. Guindon S., Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003, 52:696-704.
9. Ciotti M., Marcuccilli F., Guenci T., Babakir-Mina M., Chiodo F., Favarato M., et al. A multicenter evaluation of the Abbott RealTime HCV Genotype II assay. J Virol Methods 2010, 167:205-207.
10. Vaghefi P., Marchadier E., Dussaix E., Roque-Afonso A.M. Hepatitis C virus genotyping: comparison of the Abbott RealTime HCV Genotype II assay and NS5B sequencing. Pathol Biol (Paris) 2010, 58:175-178.
11. Shinol R.C., Gale H.B., Kan V.L. Performance of the Abbott RealTime HCV Genotype II RUO assay. J Clin Microbiol 2012, 50:3099-3101.
12. Sohn Y.H., Ko S.Y., Kim M.H., Oh H.B. Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping. Clin Chem Lab Med 2010, 48:469-474.
13. Chevaliez S., Bouvier-Alias M., Brillet R., Pawlotsky J.M. Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice. PLoS One 2009, 4. e8209.
14. Koletzki D., Dumont S., Vermeiren H., Fevery B., De Smet P., Stuyver L.J. Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assay. Clin Chem Lab Med 2010, 48:1095-1102.
15. Bouchardeau F., Cantaloube J.F., Chevaliez S., Portal C., Razer A., Lefrere J.J., et al. Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay. J Clin Microbiol 2007, 45:1140-1145.
16. Verbeeck J., Stanley M.J., Shieh J., Celis L., Huyck E., Wollants E., et al. Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0. J Clin Microbiol 2008, 46:1901-1906.
17. Nadarajah R., Khan G.Y., Miller S.A., Brooks G.F. Evaluation of a new-generation line-probe assay that detects 5' untranslated and core regions to genotype and subtype hepatitis C virus. Am J Clin Pathol 2007, 128:300-304.
18. Noppornpanth S., Sablon E., De Nys K., Truong X.L., Brouwer J., Van Brussel M., et al. Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5' untranslated regions. J Clin Microbiol 2006, 44:3969-3974.
19. González V., Gomes-Fernandes M., Bascuñana E., Matas L., Ausina V., Martró E. Relevance of accurate hepatitis C virus genotyping and subtyping in the clinical practice. Poster presented at: The International Liver Congress, 47th Annual Meeting of the European Association for the Study of the Liver, Barcelona, Spain. J Hepatol 2012, 56(Suppl. 2):S439.
20. Bracho M.A., Saludes V., Martró E., Bargalló A., González-Candelas F., Ausina V. Complete genome of a European hepatitis C virus subtype 1g isolate: phylogenetic and genetic analyses. Virol J 2008, 5:72.
21. Martró E., Valero A., Jordana-Lluch E., Saludes V., Planas R., González-Candelas F., et al. Hepatitis C virus sequences from different patients confirm the existence and transmissibility of subtype 2q, a rare subtype circulating in the metropolitan area of Barcelona, Spain. J Med Virol 2011, 83:820-826.